Skip to content
OpenCapital
Get started

Inspire Medical Systems INSP Cash ratio

Cash ratio at other companies

ResMed logo
ResMedRMD
1.2×+0.2×
LivaNova logo
LivaNovaLIVN
0.7×-0.3×
Globus Medical logo
Globus MedicalGMED
1.2×0.0×
Stryker logo
StrykerSYK
0.5×+0.2×
ITG
Integer HoldingsITGR
0×-0.1×
Medtronic logo
MedtronicMDT
0.2×0.0×

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.24B-67.8%
Enterprise value$1.18B-69.4%
P/E9.5×-48.6×
P/S1.4×-3.2×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0×0.0×
Current ratio6.3×-2.7×

Where this comes from

Calculated from Inspire Medical Systems’s reported figures.

cash and equivalents/total current liabilities=1.1×

Based on the most recent quarter.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's cash ratio?
Inspire Medical Systems (INSP) reported cash ratio of 1.1× in Q1 2026.
How has Inspire Medical Systems's cash ratio changed year-over-year?
Inspire Medical Systems's cash ratio increased by 30.3% year-over-year, from 0.8× to 1.1×.
What is the long-term trend for Inspire Medical Systems's cash ratio?
Over 5 years (2020 to 2025), Inspire Medical Systems's cash ratio has grown at a -34.7% compound annual growth rate (CAGR), from 9.2× to 1.1×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.